Liquidia Corp. (LQDA)
34.75
+0.34
(+0.99%)
USD |
NASDAQ |
Dec 29, 16:00
34.77
+0.02
(+0.06%)
Pre-Market: 08:40
Liquidia EPS Diluted (Quarterly): -0.0409 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bruker Corp. | -0.4111 |
| Integer Holdings Corp. | 1.114 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
| United Therapeutics Corp. | 7.161 |
| AIM ImmunoTech, Inc. | -1.569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.533M |
| Revenue (Quarterly) | 54.34M |
| Total Expenses (Quarterly) | 57.88M |
| Enterprise Value | 3.065B |
| Gross Profit Margin (Quarterly) | 93.65% |
| Profit Margin (Quarterly) | -6.50% |
| Earnings Yield | -4.12% |
| Normalized Earnings Yield | -4.116 |